ENZ - Enzo Biochem, Inc.

NYSE - NYSE Delayed Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow

Income Statement

Annual
All numbers in thousands
Revenue7/31/20187/31/20177/31/20167/31/2015
Total Revenue104,713107,804102,77397,599
Cost of Revenue60,38559,47857,19054,772
Gross Profit44,32848,32645,58342,827
Operating Expenses
Research Development3,2102,9283,5243,350
Selling General and Administrative49,59245,77150,12549,857
Non Recurring----
Others----
Total Operating Expenses116,877110,952113,175110,263
Operating Income or Loss-12,164-3,148-10,402-12,664
Income from Continuing Operations
Total Other Income/Expenses Net74664456,76210,372
Earnings Before Interest and Taxes-12,164-3,148-10,402-12,664
Interest Expense---136-245
Income Before Tax-11,418-2,50446,360-2,292
Income Tax Expense-1,097821,074-7
Minority Interest----
Net Income From Continuing Ops-10,321-2,50445,286-2,285
Non-recurring Events
Discontinued Operations----
Extraordinary Items----
Effect Of Accounting Changes----
Other Items----
Net Income
Net Income-10,321-2,50445,286-2,285
Preferred Stock And Other Adjustments----
Net Income Applicable To Common Shares-10,321-2,50445,286-2,285